Sunday February 24, 2019

Pregnant Women will be given Financial Aid of Rs 6,000 as part of efforts to bring down Maternal Mortality Rate: PM Narendra Modi

Currently the scheme is being implemented on a pilot basis in 53 districts with the benefit amount being Rs 4,000

0
//
An Indian woman with her little child. Pixabay

New Delhi, Dec 31, 2016: Prime Minister Narendra Modi on Saturday announced a scheme to provide pregnant women financial aid of Rs 6,000 as part of efforts to bring down the maternal mortality rate.

NewsGram brings to you latest new stories in India.

“The scheme will be applicable across the over 650 districts of the country. Under this scheme a pregnant woman will be provided with Rs 6,000 for covering hospital admission, vaccination and nutritional food,” said Modi in his special address to the nation on New Year’s Eve.

Go to NewsGram and check out news related to political current issues

“The money will be directly transferred to pregnant women bank accounts,” he said, adding that it “will greatly help in bringing down maternal mortality rate”.

Currently the scheme is being implemented on a pilot basis in 53 districts with the benefit amount being Rs 4,000. (IANS)

Next Story

Pregnant Women To Be Vaccinated Against The Deadly Ebola Virus

Ring vaccination is a strategy that prevents the spread of the disease by vaccinating only those likely to be infected with the virus.

0
Ebola
Ring vaccination is a strategy that prevents the spread of the disease by vaccinating only those likely to be infected with the virus. VOA

An independent advisory body convened by the World Health Organization (WHO) recommends pregnant women and breastfeeding women in eastern Democratic Republic of Congo be vaccinated against the deadly Ebola virus. Latest WHO figures put the number of Ebola cases in the DRC at 853, including 521 deaths since the beginning of the outbreak in August.

More than 80,000 people so far have been vaccinated against Ebola in the African country’s conflict-ridden North Kivu and Ituri provinces during the current outbreak. The vaccine is still in its experimental stage. But since 2015 it has been given to thousands of people in Africa, Europe and the United States.

The studies of the efficacy of the vaccine are not conclusive. However, they indicate the serum is safe and protects people against Ebola. On the basis of accumulated evidence, the group of immunization experts recommends continued ring vaccination for Ebola in DRC.

baby
The WHO says all vaccinated pregnant women will be closely monitored until the birth of their babies to see if there are any adverse effects. Pixabay

Ring vaccination is a strategy that prevents the spread of the disease by vaccinating only those likely to be infected with the virus. WHO spokesman, Tarek Jasarevic says the experts advise pregnant women at high risk of infection and death from Ebola should be given the vaccination.

“So, this aim, this vaccinating of women would protect them, provide them with more protection. But we also know that if we use this ring vaccination that women who are in the community that is vaccinated then have a low risk. So, it is really between risk and benefits and we hope that the use of the vaccine in pregnant women will generate some data for the future,” Jasarevic said.

ring vaccine
On the basis of accumulated evidence, the group of immunization experts recommends continued ring vaccination for Ebola in DRC. Pixabay

The group of experts advise the vaccine be given to pregnant women in their second or third trimester as well as to breastfeeding women and babies under one year old.

Also Read:Facebook’s Internal Conversation Containing Confidential Memo Leaked Online

The experts also recommend that one or more of three other new experimental Ebola vaccines be tested in areas neighboring the affected regions. They say pregnant and breastfeeding women should be included in these trials.

The WHO says all vaccinated pregnant women will be closely monitored until the birth of their babies to see if there are any adverse effects. (VOA)